Replies to post #75919 on Sixty Six Oilfield Services Inc (SSOF)

[wadirum1]

https://www.manhattanstreetcapital.com/biologx

BiologX, Inc. was formed in November 2020. BiologX, Inc. has never had any common officers, directors, or shareholders with Sixty-Six Oil Field Services, Inc. (“SSOF”) and BiologX, Inc. is not related to SSOF in any way. Click here to read more.

and when you click through, it brings you to a PDF:

https://www.manhattanstreetcapital.com/sites/default/files/PR-%20Supp.%20Info.%20SSOFZBP%2011.12.20.pdf (boldface added by me)

Sixty Six Oilfield Services, Inc.
(previously named 665 Energy, Inc. and Zimmerman BioPharma Holding, Inc.)
A Florida corporation
Trading Symbol: SSOF
Supplemental Information and Disclosure Statement
Dated November 11, 2020
1. On October 13, 2020, the board of directors of Sixty Six Oilfield Services, Inc. (the “Company”)
(whose trading symbol is “SSOF” and who was previously named 665 Energy, Inc. and Zimmerman
Biopharma Holding, Inc.), composed of David J. Wood and Ronald E. Zimmerman, approved the
rescission of the acquisition of Zimmerman Biopharmaceuticals, Inc. The rescission was requested and
agreed to by the original stockholders of Zimmerman Biopharmaceuticals, who were also Messrs. Wood
and Zimmerman. The rescission was based on omission of material adverse information about the
Company’s liabilities that was not known by Messrs. Wood or Zimmerman, but by only one former
director/officer. The rescission was also based on misrepresentations received from the Company
regarding the benefits of having an existing trading market as a basis for selling shares pursuant to a
Regulation A offering statement filed with the U.S. Securities and Exchange Commission. The Company
(as Zimmerman BioPharma Holding, Inc.) filed a Regulation A offering statement and the Commission
advised in August it was prepared to qualify the Company’s Regulation A offering statement.
Management was unable to obtain any interest in purchase or distribution of the Company’s shares
subject to qualification, in part based on the differential between the Regulation A offering price and the
public market price. In consideration for the rescission, Messrs. Wood and Zimmerman have
surrendered to the Company for cancellation the shares of the Company’s Series A-1 Preferred Stock,
which they had received as consideration for their sale of Zimmerman Biopharmaceuticals, Inc. to the
Company. The balance of the remaining Series A-1 Preferred Stock outstanding is owned by Kenneth D.
Bland who retains the right to vote as, and to convert into, eighty percent of the Company’s common
equity.
2. The board of directors also approved the withdrawal of the Company’s Regulation A offering
statement, which withdrawal was filed with the U.S. Securities and Exchange Commission on November
6, 2020. The Company does not expect objection to the withdrawal by the Commission’s staff.
3. The board of directors also approved a change in the Company’s name back to Sixty Six Oilfield
Services, Inc. from Zimmerman Biopharma Holding, Inc., which was filed with the Florida Division of
Corporations on November 2, 2020.
4. The board of directors elected Mr. Bland as a director and chief executive officer. Mr. Bland was not
informed about and has not consented to his election.
5. At surrender of the the Series A-1 Preferred Stock and filing of Articles of Amendment changing the
Company’s name, both of which have been accomplished, Messrs. Wood and Zimmerman resigned as
directors and officers of the Company.
-END-